Latest / Cyrona Cell Podcast: Stem Cell Therapy in Malaysia / Inflammation and Insulin Resistance: Can Stem Cells Help?
Transcript
- 0:00SPEAKER_02: Welcome to the Sarona Cell Podcast.
- 0:02SPEAKER_02: Um, if you look at your belly fat, you you probably think it's just this like passive storage closet for excess calories, you know?
- 0:11SPEAKER_02: Just a biological spare tire.
- 0:12SPEAKER_01: Yeah, that's a standard assumption, definitely.
- 0:14SPEAKER_02: But what if I told you that fat is actually a highly aggressive organ?
- 0:19SPEAKER_02: Yeah.
- 0:20SPEAKER_02: Like actively sending out chemical weapons that are jamming your body's ability to process sugar.
- 0:24SPEAKER_00: It sounds like science fiction, but it is it's absolutely what's happening.
- 0:28SPEAKER_02: Yeah, and so today we're going on a deep dive into this medical situation that acts like an ongoing tug of war happening completely unseen beneath the surface.
- 0:37SPEAKER_02: Our mission today is to unpack the biological mechanics of how our immune system and our blood sugar interact.
- 0:43SPEAKER_01: And, you know, we're also going to critically examine the evidence and whether stem cell therapy can actually intervene in that process.
- 0:49SPEAKER_01: Because this connection between the immune system and our metabolism, it kind of fundamentally rewrites how we have to look at chronic disease.
- 0:56SPEAKER_02: Oh, absolutely.
- 0:57SPEAKER_01: We really need to explore this intersection of insulin resistance and chronic inflammation.
- 1:02SPEAKER_01: Specifically, we're going to examine both the promising cellular science and the very grounded, realistic clinical data surrounding immune modulation.
- 1:13SPEAKER_02: Aaron Powell Because we're dealing with incredibly complex biological systems here.
- 1:17SPEAKER_02: Trevor Burrus, Jr.
- 1:17SPEAKER_01: We are.
- 1:18SPEAKER_01: And understanding them requires looking really closely at how our cells communicate and maybe more importantly, how that communication sometimes just completely breaks down.
- 1:28SPEAKER_02: Aaron Powell So let's start by looking at where this breakdown actually originates in the body.
- 1:33SPEAKER_02: Because it's honestly pretty counterintuitive.
- 1:35SPEAKER_00: It is, yeah.
- 1:36SPEAKER_02: I mean, when people think of blood sugar issues, they immediately think of the pancreas or, you know, the liver.
- 1:40SPEAKER_02: But the source data points the finger directly at adipose tissue.
- 1:44SPEAKER_01: Specifically the visceral fat, yeah.
- 1:46SPEAKER_01: The fat stored deep around the abdomen, wrapping around the organs.
- 1:49SPEAKER_02: Yeah.
- 1:49SPEAKER_02: So what is going on in that tissue?
- 1:51SPEAKER_01: Well, visceral fat is highly active.
- 1:53SPEAKER_01: It's not inert at all.
- 1:55SPEAKER_01: As a person gains weight, those fat cells physically expand to store the excess energy, which is what they're supposed to do.
- 2:01SPEAKER_01: But there's a there's a mechanical limit to this.
- 2:04SPEAKER_01: As the fat cells grow larger and larger, the local blood vessels just cannot keep up with the expansion.
- 2:11SPEAKER_02: Oh, so they're basically outgrowing their own blood supply.
- 2:14SPEAKER_01: Yeah, that is a great way to put it.
- 2:16SPEAKER_01: They outgrow the supply, so the cells begin to suffer from a lack of oxygen.
- 2:20SPEAKER_01: It's a state called hypoxia.
- 2:21SPEAKER_01: Got it.
- 2:22SPEAKER_01: And because of that, they undergo severe mechanical stress.
- 2:26SPEAKER_01: And when a cell is stressed like that, it doesn't just, you know, sit quietly and suffer.
- 2:30SPEAKER_01: It starts sending out chemical distress signals into the surrounding tissue.
- 2:34SPEAKER_02: Aaron Powell And the body interprets those distress signals as like an injury or an active infection.
- 2:41SPEAKER_02: Right.
- 2:41SPEAKER_02: It's bringing in the immune cavalry.
- 2:43SPEAKER_01: Yeah, precisely.
- 2:44SPEAKER_01: Those signals actively attract these specialized immune cells called macrophages straight into the fat tissue.
- 2:51SPEAKER_02: Aaron Powell And macrophages are kind of like the cleanup crew of the immune system normally.
- 2:55SPEAKER_01: Trevor Burrus They are, yeah.
- 2:56SPEAKER_01: But when they arrive in the visceral fat and they encounter all these stressed, dying, oxygen-starved cells, they behave as if they're fighting an active ongoing infection.
- 3:08SPEAKER_02: Aaron Powell So they just set up CAMP.
- 3:09SPEAKER_01: They set up CAMP and they begin releasing this continuous stream of inflammatory chemical messengers.
- 3:15SPEAKER_02: Aaron Powell And the key proteins mentioned in our sources for this are um TNF alpha and IL6.
- 3:22SPEAKER_01: Yeah, TNF alpha and innerlic and 6.
- 3:24SPEAKER_02: But these aren't just staying localized in the belly fat, are they?
- 3:27SPEAKER_02: Like they don't just stay in the stomach area.
- 3:29SPEAKER_01: Trevor Burrus No, and that is the critical transition here.
- 3:31SPEAKER_01: That's how it goes from a localized problem to a full-blown systemic metabolic crisis.
- 3:36SPEAKER_02: Trevor Burrus, Because they get into the blood.
- 3:38SPEAKER_01: Exactly.
- 3:38SPEAKER_01: TNF alpha and IL-6 enter the bloodstream and they circulate throughout the entire body.
- 3:44SPEAKER_01: And they have a very specific, highly disruptive capability.
- 3:47SPEAKER_02: Which is.
- 3:48SPEAKER_01: They interfere directly with the insulin receptors located on the surface of your liver cells and your skeletal muscle cells.
- 3:54SPEAKER_02: Aaron Powell Okay, so let me bring in an analogy here, because you're probably already familiar with the classic lock and key analogy for insulin.
- 4:00SPEAKER_01: Oh, sure.
- 4:00SPEAKER_01: It's the classic textbook example.
- 4:02SPEAKER_02: Yeah.
- 4:02SPEAKER_02: So normally insulin acts as the key, it turns the lock on the outside of a cell, the door opens, and glucose from your blood enters the cell to be burned for energy.
- 4:11SPEAKER_01: Aaron Powell, which is how a healthy metabolism functions.
- 4:13SPEAKER_02: But here is the fascinating twist happening in this biological loop.
- 4:17SPEAKER_02: Those inflammatory proteins, the TNF alpha and the IL6 that are being pumped out by your own fat tissue, they act like chewing gum jammed directly into the lock.
- 4:27SPEAKER_00: Yeah.
- 4:28SPEAKER_02: The insulin is still circulating, the keys are still floating around in the bloodstream, but they cannot physically turn the lock.
- 4:34SPEAKER_01: And that mechanical failure at the cellular level, that is the very definition of insulin resistance.
- 4:41SPEAKER_02: Because the keys just don't fit in.
- 4:42SPEAKER_01: Because of the gum, yeah.
- 4:43SPEAKER_01: And so because the glucose cannot enter the muscle and liver cells, it begins to back up in the bloodstream.
- 4:49SPEAKER_02: Which the pancreas then detects.
- 4:51SPEAKER_01: Right.
- 4:51SPEAKER_01: The pancreas senses this rising blood glucose and it just assumes the problem is a shortage of keys.
- 4:57SPEAKER_02: Like, oh, we need more keys to open these doors.
- 5:00SPEAKER_01: Exactly.
- 5:00SPEAKER_01: So to compensate, it strains itself to manufacture more and more insulin.
- 5:05SPEAKER_01: But the root cause is not a lack of insulin at all.
- 5:08SPEAKER_01: The cells are simply blind to the hormone because the receptors are jammed with those inflammatory signals.
- 5:14SPEAKER_02: Man, so the pancreas is just working overtime on a factory line, pumping out keys, essentially just burning itself out for nothing.
- 5:21SPEAKER_00: It really is.
- 5:21SPEAKER_02: And this dynamic explains a very alarming piece of data from the sources.
- 5:26SPEAKER_02: The 2021 National Institute of Diabetes and Digestive and Kidney Diseases report, they noted that over one in three U.S.
- 5:35SPEAKER_02: adults had borderline diabetes.
- 5:38SPEAKER_02: That is a staggering number of people walking around with this underlying inflammatory engine just running at full speed.
- 5:45SPEAKER_01: It's massive.
- 5:45SPEAKER_01: And the tricky part is many of those individuals have no idea they're caught in this inflammatory cascade.
- 5:51SPEAKER_02: Because they feel fine.
- 5:53SPEAKER_01: Because a formal diabetes diagnosis often comes years later.
- 5:56SPEAKER_01: In the early stages, the blood sugar itself might still look completely normal on a standard lab test.
- 6:01SPEAKER_02: Oh, because the pancreas is still managing to compensate.
- 6:03SPEAKER_01: Yeah, the pancreas is successfully overproducing enough insulin to force the glucose into the cells, completely masking the issue on a basic fasting glucose test.
- 6:13SPEAKER_02: But there are other warning signs, right?
- 6:14SPEAKER_02: Like routine blood work might reveal the early struggle.
- 6:17SPEAKER_01: Absolutely.
- 6:18SPEAKER_01: You might see a larger waist circumference, which indicates the expanding visceral fect we talked about.
- 6:23SPEAKER_01: And you often see rising triglycerides in the blood alongside it.
- 6:27SPEAKER_02: Okay, so if the locks are jammed with inflammatory gum, how do we actually clean them out?
- 6:33SPEAKER_02: Because the discussion of emerging treatments in our deep dive today focuses heavily on mesenchymal stem cells, or MSCs, as a potential way to interrupt this cycle.
- 6:43SPEAKER_01: Right.
- 6:43SPEAKER_01: MSCs are at the forefront of this research.
- 6:45SPEAKER_02: But I have to clarify something regarding the mechanism here, because the popular perception of stem cells is entirely wrong in this context.
- 6:53SPEAKER_01: Oh, completely.
- 6:53SPEAKER_01: People hear stem cells and they think organ regeneration.
- 6:57SPEAKER_02: Yeah.
- 6:57SPEAKER_02: Wait, so the stem cells aren't actually turning into new pancreas or liver cells.
- 7:01SPEAKER_02: They are just acting like molecular diplomats sending stand-down text messages to our aggressive immune cells.
- 7:08SPEAKER_01: That is exactly it.
- 7:09SPEAKER_01: Mesenchymal stem cells are being utilized for immune modulation.
- 7:13SPEAKER_02: Modulation.
- 7:13SPEAKER_02: So calming things down.
- 7:14SPEAKER_01: Yes, the ability to calm and regulate an overactive immune response.
- 7:18SPEAKER_01: They are absolutely not being used for tissue replacement in this metabolic context.
- 7:23SPEAKER_02: Okay, so how do they send those text messages?
- 7:25SPEAKER_01: Aaron Powell The mechanism relies on something called paracrine signaling.
- 7:30SPEAKER_01: When MSCs are introduced into the body, they naturally detect the high levels of inflammation.
- 7:35SPEAKER_02: Like they're drawn to the chemical distress signal.
- 7:38SPEAKER_01: Exactly.
- 7:39SPEAKER_01: And in response, they release microscopic packages called exosomes, along with various growth factors, into the surrounding environment.
- 7:47SPEAKER_02: Okay, so those exosomes are the text messages.
- 7:50SPEAKER_02: They're like tiny biological envelopes packed with genetic instructions and proteins.
- 7:54SPEAKER_01: Yep.
- 7:55SPEAKER_01: And those instructions are directed squarely at the immune cells, specifically those aggressive macrophages that are camped out in the fat tissue.
- 8:02SPEAKER_02: The overzealous cleanup crew.
- 8:03SPEAKER_01: Yeah.
- 8:04SPEAKER_01: The exosomes deliver a molecular signal that basically instructs the macrophages to shift away from their inflammatory attack mode state and transition into a tissue repair state.
- 8:14SPEAKER_02: Okay, and by shifting that specific immune behavior, the systemic release of TN alpha and IL-6 drops dramatically.
- 8:21SPEAKER_01: It does.
- 8:22SPEAKER_01: The supply of the inflammatory gum just dries up.
- 8:24SPEAKER_02: So the cellular chewing gum gets cleared out of the locks.
- 8:27SPEAKER_01: And the insulin receptors on the liver and muscle cells are freed up to function normally again.
- 8:33SPEAKER_02: Aaron Powell Which is incredible.
- 8:34SPEAKER_01: It is.
- 8:35SPEAKER_01: And clinical studies tracking this mechanism often show a marked lowering of C reactive protein, or CRP, which is a major systemic marker of inflammation.
- 8:44SPEAKER_01: Trevor Burrus, Jr.
- 8:44SPEAKER_02: I've seen that on blood tests, yeah.
- 8:46SPEAKER_01: And indirectly, this clearing of the receptors takes this massive crushing workload off the pancreas.
- 8:51SPEAKER_02: Right, because it doesn't need to make 10 times the normal amount of keys anymore.
- 8:54SPEAKER_01: Exactly.
- 8:55SPEAKER_01: When the pancreas doesn't have to overproduce insulin just to manage a single meal, it can actually recover, which sometimes results in modest gains in C peptide.
- 9:04SPEAKER_02: Remind me, what is C peptide?
- 9:06SPEAKER_01: C peptide is just a marker we use to measure natural insulin production in the body.
- 9:10SPEAKER_01: So seeing gains there means the pancreas is regaining some healthy function.
- 9:15SPEAKER_02: Aaron Powell Okay, but because these stem cells rely entirely on sending this very delicate, complex chemical signal, um, the environment they are grown in and the way they are processed must matter immensely, right?
- 9:27SPEAKER_02: Yeah.
- 9:27SPEAKER_02: Like if the messengers are compromised, the message never gets delivered.
- 9:30SPEAKER_01: Aaron Powell The clinical application of this biology hinges entirely on signal quality.
- 9:36SPEAKER_01: A stem cell is essentially a living factory.
- 9:39SPEAKER_01: If you place that factory into a fluctuating, poorly controlled environment, the cell itself experiences stress.
- 9:46SPEAKER_01: And a stressed stem cell does not produce robust, calming exosomes.
- 9:50SPEAKER_02: It's too busy trying to survive.
- 9:52SPEAKER_01: Right.
- 9:52SPEAKER_01: It might even release its own panic signals, which is why specialized clinics take the sourcing and manufacturing protocol so incredibly seriously.
- 10:00SPEAKER_02: And the source material highlights Sorona cell for this.
- 10:04SPEAKER_02: They operate out of qual and poor as an example of this really rigorous approach.
- 10:07SPEAKER_01: Aaron Powell, yeah.
- 10:08SPEAKER_02: They specifically utilize umbilical cord derived mesenchymal stem cells.
- 10:14SPEAKER_02: So WGMSCS Wharton's jelly mesenchymal stem cells.
- 10:17SPEAKER_02: And they're prioritizing these over, you know, cells derived from a patient's own fat or bone marrow.
- 10:22SPEAKER_01: Trevor Burrus, Jr.
- 10:22SPEAKER_01: Because utilizing Wharton's jelly from the umbilical cord provides this highly vital day zero cell.
- 10:28SPEAKER_02: Aaron Powell Day zero meaning it hasn't aged yet.
- 10:30SPEAKER_01: Exactly.
- 10:31SPEAKER_01: It hasn't been subjected to decades of environmental aging, or crucially, the patient's own chronic inflammation.
- 10:38SPEAKER_01: If you take stem cells from the fat of a patient with metabolic syndrome, those cells are already exhausted.
- 10:44SPEAKER_02: Right.
- 10:44SPEAKER_02: They've been living in that toxic soup for years.
- 10:46SPEAKER_01: Aaron Powell But the raw material is only the first step.
- 10:49SPEAKER_01: Processing these umbilical cells requires an environment that basically mimics the absolute stability of the human body.
- 10:55SPEAKER_01: Trevor Burrus, Jr.
- 10:55SPEAKER_02: Which is where all those acronyms come in.
- 10:57SPEAKER_01: Yes.
- 10:57SPEAKER_01: So Rona cell processes their WJMSCs under incredibly strict standards, BSL2 for biological safety, CGMP, which is current good manufacturing practice, and ISO 9001 quality management protocols.
- 11:11SPEAKER_02: So basically a hyper-controlled, sterile environment.
- 11:14SPEAKER_02: The temperature, the oxygen levels, the nutrients, they're all perfectly regulated.
- 11:18SPEAKER_01: Aaron Powell Because maintaining those standards ensures a highly consistent delivery system.
- 11:22SPEAKER_01: When Cyrona Cell treats their diverse base of local Malaysian patients, or, you know, the international patients who travel there specifically for care, they're relying on the fact that those umbilical cord cells will broadcast the exact same calming peracrine signals every single time.
- 11:36SPEAKER_02: Otherwise, it's a total gamble.
- 11:38SPEAKER_01: Without that rigid standardization, the inflammatory response between different batches of cells could vary wildly, rendering the whole therapy useless.
- 11:46SPEAKER_01: Aaron Powell Okay.
- 11:47SPEAKER_02: So sending these standardized calming messages sounds brilliant on a cellular level, right?
- 11:52SPEAKER_02: In a sterile laboratory.
- 11:53SPEAKER_00: It does, yeah.
- 11:54SPEAKER_02: But wait, hold on.
- 11:55SPEAKER_02: Looking at the clinical trial data, I need to question how this actually plays out in living, breathing humans who have been dealing with type 2 diabetes for years.
- 12:04SPEAKER_01: Aaron Powell It's a very fair question to ask.
- 12:06SPEAKER_02: Aaron Powell Because the source outlines a 2022 randomized placebo-controlled trial conducted in Beijing that tested umbilical cord MSC infusions in adults with type 2 diabetes mellitus.
- 12:18SPEAKER_01: Yes.
- 12:18SPEAKER_01: And that trial is a really crucial piece of evidence.
- 12:21SPEAKER_02: Right.
- 12:21SPEAKER_02: So what happened?
- 12:22SPEAKER_01: The trial specifically measured changes in insulin resistance over time, comparing patients receiving the MSCs against a control group receiving a placebo.
- 12:30SPEAKER_01: Okay.
- 12:30SPEAKER_01: And the patients in the MSC group demonstrated measurable, definitive gains in insulin sensitivity.
- 12:37SPEAKER_01: The cells successfully modulated the immune response just as the laboratory models predicted.
- 12:42SPEAKER_02: Aaron Powell Okay.
- 12:42SPEAKER_02: But looking at the fine print of the results, the HBA1C levels, which measure the three-month average of blood sugar coating the red blood cells, they didn't actually change that much.
- 12:53SPEAKER_00: They did not plummet, no.
- 12:54SPEAKER_02: And nobody in the trial stopped taking their standard diabetes medication.
- 12:59SPEAKER_02: Furthermore, the sample sizes were quite small, like fewer than 100 patients.
- 13:02SPEAKER_01: Yeah, 91 patients, I believe.
- 13:04SPEAKER_02: Right.
- 13:05SPEAKER_02: So if the blood sugar averages didn't plummet and literally no one threw away their prescription drugs, why is this trial being framed as an encouraging signal by researchers?
- 13:15SPEAKER_01: Well, the medical community views this trial as a success because it proved the underlying biological mechanism works in humans, not just in petri dishes.
- 13:23SPEAKER_02: Oh, I see.
- 13:24SPEAKER_01: The stem cells did their job.
- 13:26SPEAKER_01: They modulated the inflammation and they improved the cell's sensitivity to insulin.
- 13:30SPEAKER_01: The locks were cleaned.
- 13:32SPEAKER_02: But the house was still kind of a mess.
- 13:34SPEAKER_02: Basically.
- 13:34SPEAKER_02: Yeah.
- 13:34SPEAKER_01: The reason you do not see a miraculous overnight plunge in HBO1C is because metabolic damage is cumulative.
- 13:41SPEAKER_01: A patient with type 2 diabetes has often experienced decades of toxic glucose levels, pancreatic strain, and systemic inflammation.
- 13:49SPEAKER_02: I guess a single infusion of molecular diplomats is not going to just erase 20 years of metabolic wear and tear in a few weeks.
- 13:56SPEAKER_01: No, it's not.
- 13:56SPEAKER_01: Stem cell therapy for metabolic conditions acts as a complement to standard medical care.
- 14:02SPEAKER_02: A complement, not a cure.
- 14:03SPEAKER_01: It is not a magic eraser, and it is certainly not a replacement for traditional pharmacology.
- 14:08SPEAKER_01: The therapy creates a physiological window of opportunity by lowering the inflammatory burden, allowing the patient's own organs to begin a slow, gradual recovery process.
- 14:20SPEAKER_02: And we really have to sharply distinguish this immune-calming approach from some of the more sensational headlines circulating out there.
- 14:28SPEAKER_01: Oh, definitely.
- 14:29SPEAKER_01: There's a lot of confusion.
- 14:30SPEAKER_02: Yeah, because the the source material actually contrasts this with a highly publicized 2026 report from China, where a single patient allegedly reversed their diabetes using lab-grown eyelid cells.
- 14:42SPEAKER_01: Yeah, the 2026 case that involved tissue replacement, which is a fundamentally different biological strategy.
- 14:47SPEAKER_01: Well, they took stem cells, engineered them in a laboratory to become functional, insulin-producing beta cells, and then physically transplanted them into the patient's body to replace the failed pancreas tissue.
- 14:58SPEAKER_02: They just swapped in new parts.
- 15:00SPEAKER_01: Exactly.
- 15:00SPEAKER_01: The MSC approach we are discussing today does not replace anything.
- 15:04SPEAKER_01: It strictly leverages peracrine signaling to quiet the immune system down.
- 15:09SPEAKER_02: Which explains why reputable clinics are so careful about patient selection, I suppose.
- 15:14SPEAKER_01: They have to be.
- 15:15SPEAKER_02: If the therapy is just a complement, the underlying health of the patient dictates whether those calming signals will actually take hold.
- 15:22SPEAKER_01: A rigorous screening process is mandatory.
- 15:24SPEAKER_01: Before Sirona cell will even schedule an infusion for a patient, local or international, they mandate a comprehensive intake review.
- 15:32SPEAKER_02: What are they looking for?
- 15:33SPEAKER_01: They analyze the patient's current HBA1C, evaluate their kidney function, and ensure their overall cardiovascular health is stable.
- 15:41SPEAKER_02: Oh, so if someone is in really bad shape?
- 15:43SPEAKER_01: If a patient is in an acute state of metabolic crisis, immune modulation will not be effective.
- 15:48SPEAKER_01: The body is just too overwhelmed.
- 15:50SPEAKER_01: Right.
- 15:51SPEAKER_01: Following treatment, they track the inflammation markers on the blood sugar trends together, sharing the grounded clinical reality directly with the patient.
- 15:58SPEAKER_02: Because if a patient X-rays lifestyle is constantly triggering new inflammation, those stem cells are just fighting a losing battle.
- 16:06SPEAKER_00: Absolutely.
- 16:07SPEAKER_02: Which brings us to the catch.
- 16:09SPEAKER_02: The absolute foundation of this entire biological loop.
- 16:13SPEAKER_02: If stem cell therapy only quiet the immune response, what is required from the patient to actually maintain that progress and keep the locks clear?
- 16:21SPEAKER_01: Well, cell therapy does not and cannot replace diet, physical activity, stress management, or sleep.
- 16:28SPEAKER_01: It just can't.
- 16:28SPEAKER_02: It's not a free pass to eat junk food.
- 16:30SPEAKER_01: Not at all.
- 16:31SPEAKER_01: The therapy removes the molecular roadblocks, but the patient's daily habits build new metabolic foundation.
- 16:38SPEAKER_01: Physical activity, for example, is perhaps the most powerful tool a patient has for combating insulin resistance.
- 16:44SPEAKER_02: Yeah, and the mechanics of how muscle tissue responds to exercise are incredible.
- 16:48SPEAKER_02: The source notes that physical activity allows muscle cells to absorb glucose independent of insulin levels.
- 16:54SPEAKER_01: Independent of insulin, yeah.
- 16:55SPEAKER_02: It is basically a biological backdoor.
- 16:57SPEAKER_01: It really is.
- 16:58SPEAKER_01: When you contract your skeletal muscles, whether you're lifting weights or honestly just walking, that mechanical action triggers a distinct biochemical pathway.
- 17:08SPEAKER_01: Okay.
- 17:08SPEAKER_01: The muscle cells physically pull glucose transporters to their surface to pull sugar out of the bloodstream.
- 17:15SPEAKER_02: And they don't need insulin for that.
- 17:17SPEAKER_01: They do this without needing insulin to turn the lock at all.
- 17:20SPEAKER_01: The muscle contraction bypasses the jammed receptor entirely.
- 17:24SPEAKER_02: That's wild.
- 17:25SPEAKER_01: This mechanism is why taking even a brisk 10-minute walk after a heavy meal measurably blunts the subsequent blood sugar spike.
- 17:33SPEAKER_02: So the stem cells act like a fire extinguisher, knocking down the worst of the inflammatory flames.
- 17:38SPEAKER_02: But if you are entirely sedentary, highly stressed, sleeping poorly, and eating a diet that causes your visceral fat to expand, you are basically pouring gasoline right back onto the smoldering ashes.
- 17:50SPEAKER_01: The impact of chronic stress provides a perfect example of that gasoline, actually.
- 17:54SPEAKER_02: Oh yeah.
- 17:54SPEAKER_01: When you were chronically stressed, your adrenal glands continuously pump out cortisol, the primary fight or flight hormone.
- 18:00SPEAKER_02: Right, which kept our ancestors alive.
- 18:02SPEAKER_01: Yeah.
- 18:02SPEAKER_01: Cortisol is designed to provide immediate energy for survival, so it actively tells your liver to dump stored sugar into your blood while simultaneously worsening insulin resistance to keep that sugar available for your brain.
- 18:14SPEAKER_02: Aaron Ross Powell So it's a chemical override that completely sabotages your metabolic system if it's constantly on.
- 18:20SPEAKER_01: Yes.
- 18:20SPEAKER_01: Chronic cortisol elevation actively drives the inflammatory loop we discussed at the very beginning.
- 18:26SPEAKER_01: And poor sleep severely tanks your insulin sensitivity in a very similar way by disrupting your hormonal balance.
- 18:33SPEAKER_02: Aaron Powell The metabolic system fundamentally requires deep rest to reset its baseline.
- 18:39SPEAKER_01: It does.
- 18:39SPEAKER_01: Conversely, the Clintal data consistently shows that losing just 5 to 10% of your total body weight improves insulin sensitivity in a highly measurable way.
- 18:48SPEAKER_02: Aaron Powell Because losing that specific 5 to 10% disproportionately reduces the volume of the visceral fat.
- 18:55SPEAKER_01: Exactly.
- 18:56SPEAKER_01: You are shrinking the exact tissue that is sending out the distress signals and attracting the macrophages in the first place.
- 19:02SPEAKER_02: So you're turning off the siren.
- 19:04SPEAKER_01: Yes.
- 19:04SPEAKER_01: The clinical outcomes always reflect the synergy between the cellular environment and behavioral choices.
- 19:10SPEAKER_01: Patients who combine the cellular therapy with rigorous lifestyle modifications see the most profound lasting benefits.
- 19:18SPEAKER_02: They have to do the work.
- 19:19SPEAKER_01: They prioritize their sleep architecture.
- 19:22SPEAKER_01: They track simple everyday markers like their waist circumference to gauge the status of their visceral fat.
- 19:29SPEAKER_01: And they maintain moderate daily physical activity to keep that alternate glucose pathway open.
- 19:35SPEAKER_02: Right.
- 19:35SPEAKER_02: So you lower the systemic inflammatory noise with the MSC therapy, and you simultaneously rebuild the metabolic infrastructure with your daily habits.
- 19:44SPEAKER_01: That is the whole picture, yes.
- 19:45SPEAKER_02: Well, to pull all of these complex threads together, we have journeyed through a pretty remarkable biological landscape today.
- 19:51SPEAKER_01: We covered a lot of ground.
- 19:52SPEAKER_02: We started deep inside the visceral fat, observing how it acts as the starting point for a destructive loop running out of oxygen, pulling in the immune system's cleanup crew, and broadcasting the inflammatory proteins that ultimately jam our insulin receptors and leave glucose stranded in the blood.
- 20:09SPEAKER_01: And we then explored how mesenchymal stem cells intervene to break that loop.
- 20:13SPEAKER_01: Rather than trying to build new organs, they act as specialized messengers.
- 20:17SPEAKER_02: And molecular diplomats.
- 20:18SPEAKER_01: Yes.
- 20:19SPEAKER_01: They utilize peracrine signaling and exosomes to deliver genetic instructions that calm the overactive macrophages and modulate the systemic inflammation.
- 20:29SPEAKER_02: And we look closely at the clinical reality, noting that the trial data from Beijing showed measurable improvements in insulin sensitivity, but also proved that metabolic recovery is a slow, steady process.
- 20:41SPEAKER_01: Immune modulation is a complement to medical care, not a sudden replacement for diabetes medication.
- 20:46SPEAKER_02: And finally, we established the absolute necessity of lifestyle changes because no amount of advanced cellular signaling can overcome a foundation built on poor sleep, high cortisol, and physical inactivity.
- 20:57SPEAKER_01: Understanding the science of immune modulation gives us a really powerful new lens to view metabolic conditions.
- 21:03SPEAKER_01: It kind of strips away the mystery of why our bodies break down and it reinforces the profound daily impact of our behavioral choices on our cellular health.
- 21:11SPEAKER_02: We're so used to thinking of our body fat as just an inert storage unit, like a biological closet for excess calories.
- 21:17SPEAKER_02: But knowing what you know now, that your visceral fat is actually a highly active, loud endocrine organ constantly shouting inflammatory orders at your liver and immune system, how might that change the way you view your sleep schedule or that ten minute walk after dinner tonight?